BWX Technologies Operating Cash Flow decreased by 27.1% to $92.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 82.8%, from $50.65M to $92.60M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 5.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $59.91M | $67.26M | $160.45M | -$5.38M | $77.42M | $65.00M | $107.67M | -$13.02M | $80.61M | $74.35M | $221.76M | $33.03M | $65.89M | $32.63M | $276.88M | $50.65M | $159.04M | $143.16M | $127.00M | $92.60M |
| QoQ Change | — | +12.3% | +138.6% | -103.4% | >999% | -16.0% | +65.7% | -112.1% | +719.0% | -7.8% | +198.3% | -85.1% | +99.5% | -50.5% | +748.6% | -81.7% | +214.0% | -10.0% | -11.3% | -27.1% |
| YoY Change | — | — | — | — | +29.2% | -3.4% | -32.9% | -141.9% | +4.1% | +14.4% | +106.0% | +353.6% | -18.3% | -56.1% | +24.9% | +53.4% | +141.4% | +338.8% | -54.1% | +82.8% |